WallStreetZenWallStreetZen

NASDAQ: IVA
Inventiva Sa Stock

$3.82+0.04 (+1.06%)
Updated Mar 27, 2024
IVA Price
$3.82
Fair Value Price
N/A
Market Cap
$160.95M
52 Week Low
$2.22
52 Week High
$5.05
P/E
-1.89x
P/B
-19.73x
P/S
7.01x
PEG
N/A
Dividend Yield
N/A
Revenue
$23.45M
Earnings
-$88.00M
Gross Margin
100%
Operating Margin
-342.54%
Profit Margin
-363.3%
Debt to Equity
-10.24
Operating Cash Flow
-$70M
Beta
0.19
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

IVA Overview

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis. Inventiva S.A. was founded in 2011 and is based in Daix, France.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IVA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IVA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IVA is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
IVA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more IVA due diligence checks available for Premium users.

Be the first to know about important IVA news, forecast changes, insider trades & much more!

IVA News

Valuation

IVA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.89x
Industry
14.3x
Market
44.45x

IVA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-19.73x
Industry
6.2x

IVA's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
IVA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
IVA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$77.8M
Liabilities
$86.2M
Debt to equity
-10.24
IVA's short-term assets ($55.71M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IVA's short-term assets ($55.71M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IVA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IVA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
IVA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IVA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
IVA$160.95M+1.06%-1.89x-19.73x
GNLX$160.84M+1.18%-4.49x6.69x
NKTR$162.50M-1.67%-0.61x1.24x
BCAB$166.41M+14.95%-1.34x2.35x
IMAB$154.58M+1.63%-0.81x0.65x

Inventiva Sa Stock FAQ

What is Inventiva Sa's quote symbol?

(NASDAQ: IVA) Inventiva Sa trades on the NASDAQ under the ticker symbol IVA. Inventiva Sa stock quotes can also be displayed as NASDAQ: IVA.

If you're new to stock investing, here's how to buy Inventiva Sa stock.

What is the 52 week high and low for Inventiva Sa (NASDAQ: IVA)?

(NASDAQ: IVA) Inventiva Sa's 52-week high was $5.05, and its 52-week low was $2.22. It is currently -24.36% from its 52-week high and 72.07% from its 52-week low.

How much is Inventiva Sa stock worth today?

(NASDAQ: IVA) Inventiva Sa currently has 42,134,169 outstanding shares. With Inventiva Sa stock trading at $3.82 per share, the total value of Inventiva Sa stock (market capitalization) is $160.95M.

Inventiva Sa stock was originally listed at a price of $13.42 in Jul 10, 2020. If you had invested in Inventiva Sa stock at $13.42, your return over the last 3 years would have been -71.54%, for an annualized return of -34.22% (not including any dividends or dividend reinvestments).

How much is Inventiva Sa's stock price per share?

(NASDAQ: IVA) Inventiva Sa stock price per share is $3.82 today (as of Mar 27, 2024).

What is Inventiva Sa's Market Cap?

(NASDAQ: IVA) Inventiva Sa's market cap is $160.95M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Inventiva Sa's market cap is calculated by multiplying IVA's current stock price of $3.82 by IVA's total outstanding shares of 42,134,169.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.